Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism.
Abdulrahman H AlmaeenGomaa Mostafa-HedeabPublished in: Pharmacogenomics and personalized medicine (2021)
In HD patients, screening for ACE G2350A (rs4343) gene polymorphisms before rHuEpo administration may help predict patient response.